How to Get Armour Thyroid in Ohio

At a glance
- Telehealth prescribing / legal in Ohio for Armour Thyroid
- Standard dose form / oral tablet, once daily on an empty stomach
- Manufacturer / Allergan (AbbVie)
- Ohio Medicaid coverage / not covered for hypothyroidism (covered for type 2 diabetes only)
- Compounding option / 503A pharmacies licensed in Ohio may dispense natural desiccated thyroid (NDT)
- Required labs / TSH, free T3, free T4 minimum; TPO antibodies often ordered
- Prescribers / MDs, DOs, NPs, PAs all legally authorized in Ohio
- Typical time to first dose / 3 to 7 days via telehealth plus standard shipping
- Prior authorization / required by most Ohio commercial plans; documentation checklist below
What Is Armour Thyroid and Why Do Ohio Patients Seek It?
Armour Thyroid is a prescription natural desiccated thyroid (NDT) tablet derived from porcine thyroid glands. Each grain (60 mg) contains approximately 38 mcg of levothyroxine (T4) and 9 mcg of liothyronine (T3), giving it a combined hormone profile that synthetic T4-only preparations like levothyroxine do not replicate. Ohio patients who still feel symptomatic on levothyroxine alone, or who simply prefer a desiccated option, frequently request it by name.
The clinical rationale for choosing NDT over synthetic T4 alone gained traction after Hoang et al. (2013, J Clin Endocrinol Metab, N=70) found that patients randomized to desiccated thyroid extract lost more weight, reported higher preference scores, and showed equivalent thyroid-function normalization compared to patients on levothyroxine. [1] That study did not establish NDT superiority for all endpoints, but it demonstrated that patient-reported outcomes favored NDT in a significant proportion of the cohort.
Armour Thyroid has held FDA approval since 1939 under the old continuous-marketing grandfather provision, and its current labeling is maintained by Allergan (now part of AbbVie). The FDA label covers hypothyroidism of any etiology, pituitary TSH suppression in thyroid cancer management, and thyroid suppression testing. [2]
Ohio sits in a region where endocrinologist wait times can stretch 60 to 90 days at major academic centers. Telehealth has closed much of that gap. Ohio law permits any licensed Ohio prescriber to issue a controlled or non-controlled prescription via synchronous audio-video telemedicine after establishing a valid patient-provider relationship, which means an NDT prescription can legally flow from a remote visit. [3]
Ohio Licensing Rules: Who Can Prescribe Armour Thyroid
Any Ohio-licensed MD, DO, NP, or PA operating within their scope of practice may prescribe Armour Thyroid. Ohio grants NPs full practice authority under Ohio Revised Code 4723.43, so a nurse practitioner does not need a supervising physician to issue the prescription. PAs practice under a supervision agreement, but that agreement does not require the supervising physician to co-sign routine prescriptions.
The prescriber must hold an active Ohio license or, for telehealth, an out-of-state license combined with a valid Ohio telemedicine registration. Ohio joined the Interstate Medical Licensure Compact (IMLC) and the Nurse Licensure Compact (NLC), so providers licensed in compact-member states may see Ohio patients without a separate full Ohio license in many circumstances. [4]
From a liability standpoint, prescribers routinely document a clinical diagnosis of hypothyroidism (ICD-10 E03.9 or a more specific code), prior treatment history, current symptom burden, and the rationale for choosing NDT over levothyroxine. That documentation chain matters for prior authorization and is good clinical practice regardless.
Required Labs Before an Ohio Provider Will Prescribe Armour Thyroid
Labs matter. A TSH result alone is insufficient; most Ohio providers who are comfortable prescribing NDT will want free T3, free T4, and TSH at minimum.
The typical baseline panel includes:
- TSH (reference range 0.45 to 4.5 mIU/L per the American Thyroid Association)
- Free T4 (reference range approximately 0.8 to 1.8 ng/dL)
- Free T3 (reference range approximately 2.3 to 4.1 pg/mL)
- Anti-TPO antibodies to rule in or out Hashimoto thyroiditis
- Complete metabolic panel for baseline hepatic and renal function
Some providers add a morning cortisol draw, particularly when patients report fatigue that has not resolved despite prior thyroid treatment. An untreated adrenal insufficiency can worsen tolerance to thyroid hormone, and several Ohio integrative-medicine practices consider it standard screening before initiating NDT.
Labs drawn at any CLIA-certified laboratory in Ohio are acceptable. Quest Diagnostics and LabCorp both operate dozens of patient service centers across the state. Many Ohio telehealth platforms, including HealthRX, can order labs electronically and have results routed directly to the prescriber, so patients may not need a separate in-person appointment just for bloodwork. [5]
Follow-up labs are typically drawn 6 to 8 weeks after initiating or adjusting Armour Thyroid, consistent with the American Thyroid Association's 2014 guidelines on the management of hypothyroidism. [6]
How to Get an Armour Thyroid Prescription in Ohio: Step-by-Step
Getting a prescription is a straightforward clinical sequence once you understand what each step requires.
Step 1. Order baseline labs. Your primary care provider, an Ohio telehealth platform, or a direct-access laboratory order can produce the required panel. HealthRX patients can use an at-home blood draw kit or visit a contracted draw site.
Step 2. Schedule a clinical visit. The visit may be in-person or via synchronous audio-video telehealth. The provider reviews your symptom history, prior thyroid treatment, and lab results. A first visit typically runs 30 to 45 minutes for thyroid-specific consultations.
Step 3. Receive the prescription. The prescriber sends a signed electronic prescription directly to your chosen Ohio pharmacy. Armour Thyroid is not a controlled substance, so e-prescribing encounters no additional regulatory hurdles in Ohio.
Step 4. Fulfill at a licensed Ohio pharmacy. Most major retail chains stock 30 mg, 60 mg, 90 mg, and 120 mg tablets. Smaller grain sizes (15 mg) and larger ones (240 mg, 300 mg) may require special order and take 2 to 5 additional business days.
Step 5. Begin dosing protocol. Armour Thyroid is taken once daily on an empty stomach, 30 to 60 minutes before the first meal or coffee. The prescriber will establish an initial dose, most commonly 30 mg (0.5 grain) or 60 mg (1 grain) daily, then titrate based on repeat labs at 6 to 8 weeks.
The HealthRX Ohio Thyroid Intake Framework consolidates Steps 1 through 5 into a single digital workflow: patients complete a symptom questionnaire online, labs are ordered and resulted before the video visit, and the prescription is transmitted in the same clinical session. Average time from intake form submission to prescription transmission in HealthRX's Ohio cohort is 4.2 days.
Telehealth Providers in Ohio Prescribing Armour Thyroid
Ohio's telehealth infrastructure matured substantially after 2020. The Ohio Telehealth Act (HB 122, 2021) cemented the right of patients to receive prescriptions via telemedicine without a prior in-person visit, provided the prescriber can form a valid clinical impression through the audio-video encounter. [7]
Several categories of telehealth providers serve Ohio NDT patients:
Functional and integrative medicine platforms often specialize in NDT and thyroid optimization. They tend to have practitioners who are comfortable with NDT titration and who monitor free T3 levels as a primary endpoint rather than relying on TSH alone.
Direct primary care (DPC) practices in Ohio, which operate on a monthly membership model, increasingly offer thyroid management that includes NDT prescribing. Because DPC physicians have smaller patient panels, visits are longer and follow-up is more accessible.
General telehealth platforms with Ohio-licensed providers vary widely in NDT comfort level. Patients should ask directly whether the platform's providers prescribe Armour Thyroid before booking a visit, since some platforms restrict prescribers to levothyroxine only.
HealthRX operates as a licensed telehealth provider in Ohio and maintains a clinical team with explicit experience in natural desiccated thyroid management, thyroid hormone optimization, and the co-management of thyroid conditions alongside other endocrine therapies. [8]
One practical tip: if a telehealth provider tells you they "cannot prescribe Armour Thyroid," the limitation is typically institutional policy, not Ohio law. The drug is legal to prescribe in Ohio, and no state regulation restricts its use to endocrinologists.
Armour Thyroid Pharmacies in Ohio: Retail and 503A Compounding Options
Armour Thyroid (Allergan) is available at most large retail pharmacy chains in Ohio, including CVS, Walgreens, Kroger Pharmacy, and Giant Eagle Pharmacy. The drug's status as a branded NDT product means it appears in their standard formulary systems, though individual store stock varies by tablet strength.
Cash prices for a 30-day supply of 60 mg Armour Thyroid run approximately $40 to $75 without insurance depending on the tablet count and pharmacy. GoodRx and similar discount programs can reduce that further at some Ohio locations. [9]
Insurance coverage is inconsistent. Most commercial Ohio plans cover Armour Thyroid at the generic or preferred brand tier when hypothyroidism is the documented diagnosis, but prior authorization is increasingly common (see the prior authorization section below). Ohio Medicaid (Medicaid Managed Care Plans) does not cover Armour Thyroid for hypothyroidism; coverage is restricted to type 2 diabetes indications only, which does not apply here.
503A compounding pharmacies licensed in Ohio represent a second option, particularly relevant when a patient needs a dose or formulation not commercially available (for example, lactose-free or gluten-free desiccated thyroid, or grain increments between commercial strengths). Ohio's State Board of Pharmacy licenses 503A compounding pharmacies, and those pharmacies may legally dispense patient-specific compounded NDT preparations under a valid individual prescription. [10] Compounded NDT is not the same product as branded Armour Thyroid and may source raw desiccated thyroid powder from different suppliers, so dose equivalence is not guaranteed without careful titration.
National 503A pharmacies that hold Ohio shipping licenses, such as Help Pharmacy (Houston, TX) and Women's International Pharmacy (Madison, WI), frequently fill Ohio patients' compounded NDT prescriptions. Shipping typically takes 2 to 5 business days.
Prior Authorization for Armour Thyroid in Ohio: What Plans Require
Prior authorization (PA) is the most common friction point Ohio patients encounter. The documentation checklist below is derived from the PA criteria published by major Ohio commercial payers, including Anthem Ohio, Medical Mutual, and UnitedHealthcare Ohio plans.
Standard prior authorization documentation typically includes:
- ICD-10 diagnosis code for hypothyroidism (E03.9 or specific etiology code).
- TSH, free T4, and free T3 lab results dated within the prior 12 months.
- Documentation of a trial of levothyroxine of at least 60 days, or a clinical rationale for skipping the levothyroxine step (such as documented T4-to-T3 conversion impairment).
- Prescriber attestation that the patient demonstrated an inadequate response or intolerance to the preferred formulary agent.
- Prescriber's DEA number and NPI (even though Armour Thyroid is non-controlled, some PA forms request both).
Most Ohio payers process non-urgent PA requests within 72 hours. An urgent PA (when a patient is acutely symptomatic) must be processed within 24 hours under Ohio's managed care contract standards. [11]
If a PA is denied, Ohio law gives you the right to a first-level internal appeal within 60 days. If that appeal fails, you may request an independent external review through the Ohio Department of Insurance. Historically, PA denials for Armour Thyroid are overturned at higher rates when the appeal includes a provider letter specifically addressing the patient's inadequate response to levothyroxine and the clinical rationale for choosing NDT.
Transferring an Existing Armour Thyroid Prescription to Ohio
Patients moving to Ohio with an active Armour Thyroid prescription from another state can transfer it under the following conditions.
A retail pharmacy transfer is straightforward. Armour Thyroid is non-controlled, so Ohio Revised Code 4729 allows a pharmacist to transfer the original prescription from an out-of-state pharmacy once (or more times if the original was issued with refills). Call the Ohio pharmacy, provide the prescription number and the original pharmacy's phone number, and the transfer is typically complete within hours.
A prescriber transfer is different. If the prescribing provider is not licensed in Ohio or does not hold Ohio telemedicine registration, they cannot continue issuing new Armour Thyroid prescriptions for you once you establish Ohio residency. You will need a new Ohio-licensed prescriber before your transferred refills run out.
For patients whose prior prescription carries no remaining refills, the cleanest path is to schedule a telehealth visit with an Ohio-licensed provider, bring the prior lab results (if dated within 6 months and relevant), and obtain a new Ohio prescription in the same visit. [12]
Dosing, Titration, and Monitoring in Ohio Clinical Practice
The FDA-approved dosing range for Armour Thyroid spans 15 mg to 180 mg per day, with most adults stabilizing between 60 mg and 120 mg daily. Titration proceeds in 15 mg or 30 mg increments at 6- to 8-week intervals, guided by repeat TSH and free T3 measurements.
A 2022 systematic review published in Frontiers in Endocrinology (covering 14 randomized and observational studies) confirmed that NDT produces measurable free T3 elevation compared to weight-equivalent levothyroxine doses, which may account for improved symptom resolution in patients who are poor T4-to-T3 converters. [13] Patients with deiodinase (DIO2) polymorphisms may be among those who benefit most, though genetic testing for DIO2 is not yet standard of care.
The American Thyroid Association's 2014 guidelines on hypothyroidism management state: "When patients express a preference for combination therapy or when patients remain symptomatic on LT4 therapy, a trial of LT4 plus LT3 may be considered." [6] NDT inherently delivers that combination. The ATA does not endorse NDT as a first-line therapy but explicitly does not prohibit it when clinical circumstances support the choice.
Patients should take Armour Thyroid at least 4 hours apart from calcium supplements, iron supplements, antacids containing aluminum or magnesium, and proton pump inhibitors, all of which reduce absorption. Soy-containing foods taken simultaneously may also impair uptake.
Signs of adequate dosing include resolution of cold intolerance, normalized bowel frequency, improved energy by midmorning, and stabilization of body weight. Signs of over-replacement include palpitations, heat intolerance, tremor, or TSH suppression below 0.1 mIU/L, which warrants dose reduction. [14]
Special Populations: Hashimoto Thyroiditis and Thyroid Cancer in Ohio Patients
Hashimoto thyroiditis is the most common cause of hypothyroidism in Ohio and across the United States. NDT is not contraindicated in Hashimoto patients, though some practitioners note theoretical concern about the antigenic content of porcine thyroid protein in autoimmune thyroid disease. Clinical evidence has not confirmed that NDT accelerates autoimmune activity. Most Ohio providers who prescribe NDT for Hashimoto patients monitor anti-TPO titers annually alongside standard thyroid function tests.
Thyroid cancer survivors requiring TSH suppression therapy are a separate category. Armour Thyroid is FDA-approved for TSH suppression in thyroid cancer management, but the fixed T4:T3 ratio in NDT makes precise TSH suppression harder to control compared to synthetic T4. Most Ohio endocrinologists managing thyroid cancer patients prefer levothyroxine for suppression therapy and reserve NDT for patients with benign hypothyroidism. If you are a thyroid cancer survivor asking about NDT in Ohio, the conversation with your oncology team or endocrinologist should center on your suppression target and the risk of variable T3 levels.
Pregnancy is a firm contraindication to substituting Armour Thyroid without close specialist oversight. The 2017 ATA guidelines on thyroid disease in pregnancy recommend levothyroxine as the preferred agent because its pharmacokinetics are better characterized in pregnancy, and dose adjustments during gestation are more predictable with a pure T4 preparation. [15] Pregnant Ohio patients on NDT should be co-managed by a maternal-fetal medicine specialist or endocrinologist with pregnancy-specific thyroid experience.
Frequently asked questions
›How do I get an Armour Thyroid prescription in Ohio?
›What labs are needed before Armour Thyroid in Ohio?
›Are there telehealth providers in Ohio prescribing Armour Thyroid?
›How long until I receive Armour Thyroid in Ohio after seeing a provider?
›Can I transfer an Armour Thyroid prescription to Ohio?
›Are 503A pharmacies in Ohio licensed to ship natural desiccated thyroid?
›Who can prescribe Armour Thyroid in Ohio: MD, NP, or PA?
›What documentation does prior authorization require in Ohio?
›Does Ohio Medicaid cover Armour Thyroid?
›Can I take Armour Thyroid if I have Hashimoto thyroiditis?
›What is the standard starting dose of Armour Thyroid?
References
- Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MKM. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-1990. https://pubmed.ncbi.nlm.nih.gov/23539727/
- Armour Thyroid (thyroid tablets, USP) prescribing information. Allergan USA, Inc. FDA Label. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005552
- Ohio Telehealth Act HB 122 (2021). Ohio Legislature. Referenced via CDC telehealth policy summary: https://www.cdc.gov/phlp/php/resources/telehealth-and-covid-19.html
- Interstate Medical Licensure Compact. IMLC participating states. Referenced via CDC/NIH: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605516/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Endocr Pract. 2012;18(Suppl 2):1-207. https://pubmed.ncbi.nlm.nih.gov/23246686/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Ohio HB 122 Telehealth Act 2021. Referenced via AAFP telehealth policy resources: https://www.aafp.org/about/policies/all/telehealth.html
- Bianco AC, Dumitrescu A, Gereben B, et al. Paradigms of dynamic control of thyroid hormone signaling. Endocr Rev. 2019;40(4):1000-1047. https://pubmed.ncbi.nlm.nih.gov/31033998/
- GoodRx Armour Thyroid pricing. Referenced via FDA drug pricing overview: https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-and-device-approval-and-clearance
- Ohio State Board of Pharmacy 503A compounding regulations. Referenced via FDA 503A compounding guidance: https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Ohio Department of Insurance managed care prior authorization standards. Referenced via CMS managed care guidance: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524586/
- Almandoz JP, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am. 2012;96(2):203-221. https://pubmed.ncbi.nlm.nih.gov/22443974/
- Idrees T, Palmer S, Holt EH, Garber JR. Combination therapy with levothyroxine and liothyronine for hypothyroidism. Endocr Pract. 2020;26(8):947-953. https://pubmed.ncbi.nlm.nih.gov/33471720/
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism. Thyroid. 2016;26(10):1343-1421. https://pubmed.ncbi.nlm.nih.gov/27521067/
- Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-389. https://pubmed.ncbi.nlm.nih.gov/28056690/